home / stock / cdmop / cdmop news

CDMOP News and Press, Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock From 12/02/19

Stock Information
Company Name: Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock
Stock Symbol: CDMOP
Market: NASDAQ
Website: avidbio.com
Menu
CDMOP CDMOP Quote CDMOP Short CDMOP News CDMOP Articles CDMOP Message Board
Get CDMOP Alerts

News, Short Squeeze, Breakout and More Instantly...
CDMOP - Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019

TUSTIN, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical com...
CDMOP - Avid Bioservices Names Richard Richieri as Chief Operations Officer

TUSTIN, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotec...

CDMOP - Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure

TUSTIN, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical com...

CDMOP - Fortress Biotech Preferred: Another Look At This Speculative 11.5% Yielder With More Cash Than Debt

Fortress Biotech ( FBIO ) has made significant progress since my 11/24/2018 article on the Fortress Biotech Inc. 9.375% Cum Conv Perp Red Pfd Registered Shs Series ( FBIOP ). Although FBIOP remains a speculative issue, it has appreciated in price from $17.58 to $20.00 since my last artic...
CDMOP - Avid Bioservices Announces Termination of Stockholder Rights Plan

TUSTIN, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical co...

CDMOP - Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments

-- Achieved First Quarter Revenue of $15.3 Million; Reaffirms Fiscal 2020 Projected Revenue of $64 to $67 Million -- -- Signed Two Contract Manufacturing Agreements with New and Existing Customers -- TUSTIN, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc.&#x...

CDMOP - Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019

TUSTIN, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical com...
CDMOP - Avid Bioservices Announces Appointment of Catherine Mackey, Ph.D. to Board of Directors

TUSTIN, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical com...

CDMOP - Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers

Company Signs Top Ten Global Pharmaceutical Company as New Client and Expands Relationship with Existing Biotechnology Company Customer Agreements Include Process Transfer, Process Development and Clinical Manufacturing for Novel Therapeutic Candidates TUSTIN, Calif., July 08, 2019...

CDMOP - Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2019 and Recent Developments

  -- Achieved Fourth Quarter Revenue of $17.1 Million, an Increase of 146%  Compared to Prior Year Quarter -- -- Generated Income From Continuing Operations During the Fourth Quarter of Fiscal 2019 -- -- Increasing Demand from Customers Expected to Drive Continued R...
Previous 10 Next 10